Medicover AB (publ)
MCOV-B
Rank in Stocks
#3955
Established in 1995 and headquartered in Stockholm, Sweden, Medicover AB (publ)... Established in 1995 and headquartered in Stockholm, Sweden, Medicover AB (publ) is a prominent international provider of both healthcare and diagnostic services. The company operates across numerous countries, including Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It is structured into two main divisions: Healthcare Services and Diagnostic Services. Through its diagnostic division, Medicover performs a comprehensive array of specialized tests, which include analyses for allergy and autoimmune conditions; bacteriology and parasitology; biochemistry and immunochemistry; blood group diagnostics and transfusion medicine; tumour markers; clinical chemistry; cellular analyses like cytology, haematology, and histopathology; human genetics; hygiene; general immunology; infectious diseases; microbiology; molecular biology; and pharmacology/toxicology. Medicover maintains a substantial operational footprint, encompassing 97 clinical laboratories, 733 blood-drawing points, and 26 clinics dedicated to diagnostic services across 10 countries. Its healthcare segment further comprises 117 medical clinics, 20 fertility clinics, 52 dental clinics, 25 hospitals, and 25 gyms. The company caters to a broad customer base, serving corporate entities, private individuals, direct patients, and public sector payers.
Share Price
$27.03
Market Cap
$4.11B
Change (1 day)
0.56%
Change (1 year)
-1.61%
Country
SE
Trade Medicover AB (publ) (MCOV-B)
Category
Healthcare
Earnings for Medicover AB (publ) (MCOV-B)
Earnings in 2026 TTM: 0
According to Medicover AB (publ) latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Medicover AB (publ) from 2014 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2025 | $115.45M | 451.98% |
| 2024 | $20.92M | -19.83% |
| 2023 | $26.09M | 22.84% |
| 2022 | $21.24M | -87.01% |
| 2021 | $163.52M | 259.97% |
| 2020 | $45.43M | 21.58% |
| 2019 | $37.36M | -5.49% |
| 2018 | $39.53M | 17.66% |
| 2017 | $33.60M | 159.60% |
| 2016 | $12.94M | -28.63% |
| 2015 | $18.13M | 16.18% |
| 2014 | $15.61M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $9.87B | - |
US
|
|
| - | - |
DE
|
|
| $3.87B | - |
US
|
|
| $687.82M | - |
SA
|
|
| $1.25B | - |
BR
|
